Domov › Generalizirana anksiozna motnja › Florida
Klinične študije za Generalizirana anksiozna motnja v Florida
7 študij za Generalizirana anksiozna motnja išče udeležence na lokacijah v Florida.
Mesta v Florida
Uradno besedilo študije (angleško)
A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)
- Sunshine Medical Research Studies Inc, Miami
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07807865Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
- Premier Clinical Research, Miami
- Global Medical Institutes, Miami
- Miami Dade Medical Research Institute, Miami
- in še 3
Vključevanje udeležencevFaza 2
Vse starosti · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06480383Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
- Miami Dade Medical Research Institute, Miami
- University of South Florida, Tampa
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06701903RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
- Innovative Clinical Research, Inc., Lauderhill
- University of South Florida, Tampa
Vključevanje udeležencevFaza 2
Starost 18–74 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT07489651A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
- Sarkis Clinical Trials - Gainesville, Gainesville
- Clinical Neuroscience Solutions, LLC, Jacksonville
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07759128A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
- Clinical Neuroscience Solutions Inc. (CNS) - Orlando, Orlando
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT07767903Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
- Cns Healthcare - Jacksonville /ID# 268588, Jacksonville
- Accel Research Sites Network - St. Pete /ID# 267821, Largo
- K2 Medical Research, LLC /ID# 267841, Maitland
- in še 3
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 17. jun. 2026 · NCT06846320Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.